Clinical Trial

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

Completed
View on ClinicalTrials.gov →
Summary
The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-28
notable Enrollment reduced: 150 -> 73 participants 2026-07-28
Trial Details
NCT Number NCT05699460
Lead Sponsor AskBio Inc
Conditions Parkinson's Disease, Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy
Enrollment 73 participants
Start Date 2022-09-29
Primary Completion 2025-11-04 (estimated)
Study Completion 2025-11-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-27